Lymphangiogenesis in tissue-engineered small intestine

Mark S. Duxbury, Tracy C. Grikscheit, James Gardner-Thorpe, Flavio G. Rocha, Hiromichi Ito, Alexander Perez, Stanley W. Ashley, Joseph P. Vacanti, Edward E. Whang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background. Lymphangiogenesis, the formation of lymphatic vessels, has not been reported in engineered tissue. The purpose of this study was to characterize lymphangiogenesis in tissue-engineered small intestine. Methods. Biodegradable polymer scaffolds seeded with intestinal organoid units were implanted into syngenic recipient rats. Twenty-three neointestinal grafts were harvested from adult rat recipients 1 to 8 weeks postimplantation. Cells expressing the lymphatic endothelial marker vascular endothelial growth factor receptor (VEGFR)-3 were detected immunohistochemically. The lymphangiogenic growth factor VEGF-C was quantified by enzyme-linked immunoadsorbent assay. Results. Between the first and eighth weeks, neointestinal cysts increased in volume and mass. Muscular and mucosal layers increased in thickness and developed to resemble normal intestine histologically. The proportion of neointestinal VEGFR-3-positive cells increased and ultimately, tubular structures developed that resembled lymphatics architecturally, were distinct from CD34-positive blood vessels, and lacked luminal erythrocytes. Conclusion. Lymphangiogenesis occurs in tissue-engineered small intestine. This is the first demonstration of lymphatic vessels in an engineered tissue.

Original languageEnglish (US)
Pages (from-to)1162-1166
Number of pages5
JournalTransplantation
Volume77
Issue number8
StatePublished - Apr 27 2004
Externally publishedYes

Fingerprint

Lymphangiogenesis
Small Intestine
Vascular Endothelial Growth Factor Receptor-3
Lymphatic Vessels
Organoids
Vascular Endothelial Growth Factor C
Immunosorbents
Intestines
Blood Vessels
Cysts
Intercellular Signaling Peptides and Proteins
Polymers
Endothelial Cells
Erythrocytes
Transplants
Enzymes

ASJC Scopus subject areas

  • Transplantation

Cite this

Duxbury, M. S., Grikscheit, T. C., Gardner-Thorpe, J., Rocha, F. G., Ito, H., Perez, A., ... Whang, E. E. (2004). Lymphangiogenesis in tissue-engineered small intestine. Transplantation, 77(8), 1162-1166.

Lymphangiogenesis in tissue-engineered small intestine. / Duxbury, Mark S.; Grikscheit, Tracy C.; Gardner-Thorpe, James; Rocha, Flavio G.; Ito, Hiromichi; Perez, Alexander; Ashley, Stanley W.; Vacanti, Joseph P.; Whang, Edward E.

In: Transplantation, Vol. 77, No. 8, 27.04.2004, p. 1162-1166.

Research output: Contribution to journalArticle

Duxbury, MS, Grikscheit, TC, Gardner-Thorpe, J, Rocha, FG, Ito, H, Perez, A, Ashley, SW, Vacanti, JP & Whang, EE 2004, 'Lymphangiogenesis in tissue-engineered small intestine', Transplantation, vol. 77, no. 8, pp. 1162-1166.
Duxbury MS, Grikscheit TC, Gardner-Thorpe J, Rocha FG, Ito H, Perez A et al. Lymphangiogenesis in tissue-engineered small intestine. Transplantation. 2004 Apr 27;77(8):1162-1166.
Duxbury, Mark S. ; Grikscheit, Tracy C. ; Gardner-Thorpe, James ; Rocha, Flavio G. ; Ito, Hiromichi ; Perez, Alexander ; Ashley, Stanley W. ; Vacanti, Joseph P. ; Whang, Edward E. / Lymphangiogenesis in tissue-engineered small intestine. In: Transplantation. 2004 ; Vol. 77, No. 8. pp. 1162-1166.
@article{96e65a638c2b4478873f839303e57938,
title = "Lymphangiogenesis in tissue-engineered small intestine",
abstract = "Background. Lymphangiogenesis, the formation of lymphatic vessels, has not been reported in engineered tissue. The purpose of this study was to characterize lymphangiogenesis in tissue-engineered small intestine. Methods. Biodegradable polymer scaffolds seeded with intestinal organoid units were implanted into syngenic recipient rats. Twenty-three neointestinal grafts were harvested from adult rat recipients 1 to 8 weeks postimplantation. Cells expressing the lymphatic endothelial marker vascular endothelial growth factor receptor (VEGFR)-3 were detected immunohistochemically. The lymphangiogenic growth factor VEGF-C was quantified by enzyme-linked immunoadsorbent assay. Results. Between the first and eighth weeks, neointestinal cysts increased in volume and mass. Muscular and mucosal layers increased in thickness and developed to resemble normal intestine histologically. The proportion of neointestinal VEGFR-3-positive cells increased and ultimately, tubular structures developed that resembled lymphatics architecturally, were distinct from CD34-positive blood vessels, and lacked luminal erythrocytes. Conclusion. Lymphangiogenesis occurs in tissue-engineered small intestine. This is the first demonstration of lymphatic vessels in an engineered tissue.",
author = "Duxbury, {Mark S.} and Grikscheit, {Tracy C.} and James Gardner-Thorpe and Rocha, {Flavio G.} and Hiromichi Ito and Alexander Perez and Ashley, {Stanley W.} and Vacanti, {Joseph P.} and Whang, {Edward E.}",
year = "2004",
month = "4",
day = "27",
language = "English (US)",
volume = "77",
pages = "1162--1166",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Lymphangiogenesis in tissue-engineered small intestine

AU - Duxbury, Mark S.

AU - Grikscheit, Tracy C.

AU - Gardner-Thorpe, James

AU - Rocha, Flavio G.

AU - Ito, Hiromichi

AU - Perez, Alexander

AU - Ashley, Stanley W.

AU - Vacanti, Joseph P.

AU - Whang, Edward E.

PY - 2004/4/27

Y1 - 2004/4/27

N2 - Background. Lymphangiogenesis, the formation of lymphatic vessels, has not been reported in engineered tissue. The purpose of this study was to characterize lymphangiogenesis in tissue-engineered small intestine. Methods. Biodegradable polymer scaffolds seeded with intestinal organoid units were implanted into syngenic recipient rats. Twenty-three neointestinal grafts were harvested from adult rat recipients 1 to 8 weeks postimplantation. Cells expressing the lymphatic endothelial marker vascular endothelial growth factor receptor (VEGFR)-3 were detected immunohistochemically. The lymphangiogenic growth factor VEGF-C was quantified by enzyme-linked immunoadsorbent assay. Results. Between the first and eighth weeks, neointestinal cysts increased in volume and mass. Muscular and mucosal layers increased in thickness and developed to resemble normal intestine histologically. The proportion of neointestinal VEGFR-3-positive cells increased and ultimately, tubular structures developed that resembled lymphatics architecturally, were distinct from CD34-positive blood vessels, and lacked luminal erythrocytes. Conclusion. Lymphangiogenesis occurs in tissue-engineered small intestine. This is the first demonstration of lymphatic vessels in an engineered tissue.

AB - Background. Lymphangiogenesis, the formation of lymphatic vessels, has not been reported in engineered tissue. The purpose of this study was to characterize lymphangiogenesis in tissue-engineered small intestine. Methods. Biodegradable polymer scaffolds seeded with intestinal organoid units were implanted into syngenic recipient rats. Twenty-three neointestinal grafts were harvested from adult rat recipients 1 to 8 weeks postimplantation. Cells expressing the lymphatic endothelial marker vascular endothelial growth factor receptor (VEGFR)-3 were detected immunohistochemically. The lymphangiogenic growth factor VEGF-C was quantified by enzyme-linked immunoadsorbent assay. Results. Between the first and eighth weeks, neointestinal cysts increased in volume and mass. Muscular and mucosal layers increased in thickness and developed to resemble normal intestine histologically. The proportion of neointestinal VEGFR-3-positive cells increased and ultimately, tubular structures developed that resembled lymphatics architecturally, were distinct from CD34-positive blood vessels, and lacked luminal erythrocytes. Conclusion. Lymphangiogenesis occurs in tissue-engineered small intestine. This is the first demonstration of lymphatic vessels in an engineered tissue.

UR - http://www.scopus.com/inward/record.url?scp=2342531032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342531032&partnerID=8YFLogxK

M3 - Article

C2 - 15114078

AN - SCOPUS:2342531032

VL - 77

SP - 1162

EP - 1166

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 8

ER -